Wordt geladen...
A new precision medicine initiative at the dawn of exascale computing
Which signaling pathway and protein to select to mitigate the patient’s expected drug resistance? The number of possibilities facing the physician is massive, and the drug combination should fit the patient status. Here, we briefly review current approaches and data and map an innovative patient-spe...
Bewaard in:
| Gepubliceerd in: | Signal Transduct Target Ther |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group UK
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7785737/ https://ncbi.nlm.nih.gov/pubmed/33402669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-00420-3 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|